CURON BIOPHARMA
Curon Biopharma is a developer of drugs intended designed for immuno-oncology therapies. The company's drugs consist of multiple class-leading cancer immunotherapeutic agents in the world that could address the shortcomings of current cancer treatment paradigm, enabling a physician to provide advanced cancer immunotherapies to their patients.
CURON BIOPHARMA
Industry:
Biopharma Biotechnology Health Care Pharmaceutical
Founded:
2018-01-01
Address:
Shanghai, Shanghai, China
Country:
China
Website Url:
http://www.curonbiopharma.com
Total Employee:
1+
Status:
Closed
Total Funding:
150 M USD
Similar Organizations
RIST Neurovascular
RIST Neurovascular is a healthcare company.
Ractigen Therapeutics
Ractigen is an early-stage pharmaceutical company.
Ruixun Biotech
Ruixun Biotech is a Healthcare company.
Neurogami Medical
Neurogami Medical is a Health Care Company.
Nuevocor
Nuevocor operates as a preclinical-stage biotech company.
Naxions
Naxions is a Healthcare company.
Neuraly
Neuraly is a startup biotech company.
NeuCures
NeuCures is a health care services company.
Nuoling Biotech
Nuoling Biotech is a Healthcare company.
Vitas Pharma
Vitas Pharma is a drug discovery company.
Motherhood India
Motherhood India is a healthcare startup.
Maver Medical
Maver Medical is a Healthcare company.
Medrx
Medrx is a pharmaceutical company.
Mednow.ca
Mednow.ca is a virtual pharmacy and healthcare platform.
LinaTech
LinaTech is a Healthcare company.
Life Create
Life Create is a healthcare company.
La Renon
La Renon is a global healthcare company.
Lyvgen Biopharma
Lyvgen Biopharma is a Healthcare Company.
lafool
lafool is a health care company.
Asieris Pharmaceuticals
Asieris Pharmaceuticals is a Chinese biotech company.
AVATAMED
Biotechnology, Biopharmaceutical
Arix Bioscience
Arix Bioscience is a global venture capital company that invests in breakthrough biotechnology companies.
Arbutus Biopharma
Arbutus Biopharma Corporation is a publicly-traded biopharmaceutical company.
EOC Pharma Group
EOC Pharma is an integrated biopharmaceutical company.
Enthera
Enthera is a biotech company whose mission is to find new therapeutic approaches to treat diabetes and gastrointestinal complication.
BlueRock Therapeutics
It is a regenerative medicine company.
Brise Pharma
Brise Pharma operates in the scientific research and technical service industry.
Bioheng
Bioheng is a high-tech R&D innovation company.
BioMatrix Specialty Pharmacy
BioMatrix Specialty Pharmacy is a specialty pharmacy platform company.
BrightGene
BrightGene is a biopharma company.
Bioknow
Bioknow is a Healthcare company.
BOL Pharma
BOL Pharma is a Pharmaceuticals based company.
FiNC Technologies
FiNC Technologies is a health care company.
Theseus Pharmaceuticals
Theseus Pharmaceuticals is a technology-based company.
Truemeds
Truemeds is a health-tech startup that makes healthcare accessible to patients.
Tekeluo Biotech
Tekeluo Biotech is a Healthcare company.
Trinomab
Trinomab is a Healthcare company.
Touch
Touch is a Healthcare company.
Jianke
Jianke is anonline B2C pharmacy and healthcare services platform.
Jinqi Group
Jinqi Group is a Healthcare company.
Quiknos
Quiknos is a Healthcare company.
Kangpu Biopharmaceuticals, Ltd.
Kangpu Bio-Pharma is a clinical stage company.
Wanxu Software
Wanxu Software is a healthcare company.
SanBio
SanBio is a regenerative medicine company.
SA Biotech
SA Biotech is a Healthcare company.
Shanghai LinkedCare Information Technology
Shanghai LinkedCare Information Technology is a Healthcare company.
Stork Healthcare
Stork Healthcare is a Healthcare Company.
SIRU+
SIRU+ is a healthcare marketing company.
Strides Pharma Science
Strides Arcolab is a pharmaceutical company.
Samsung Bioepis
Samsung Bioepis is a biopharmaceutical company.
StanPlus
A Health And Healthcare Company.
Shengmei Biotech
Shengmei Biotech is a Healthcare company.
Dizal Pharma
Dizal Pharma is a research-based biotechnology company.
dClinic.co
dClinic.co is a dedicated Healthcare Blockchain company.
D&D Pharmatech
D&D Pharmatech is a Health care Company.
Doctor Anywhere
Doctor Anywhere is a telehealth company .
Healsun Biopharm
Healsun Biopharm is a pharmaceutical company.
Hinova Pharma
Hinova Pharma is a pharmaceutical company.
Hangzhou Just Biotherapeutics (Just China)
Hangzhou Just Biotherapeutics is a comprehensive high-tech design company.
Huadao Biopharma
Huadao Biopharma is a biomedical company that specializes in cellular immunotherapy.
Immunophage Biotech
Immunophage Biotech is a Nanjing-based pharmaceutic company.
ImmunoBrain Checkpoint
ImmunoBrain Checkpoint is a biopharmaceutical company.
Genedock
Genedock is a Healthcare company.
GloriousMed Technology
GloriousMed Technology is a Healthcare company.
GV20 Oncotherapy
GV20 Oncotherapy is a Healthcare Company.
OPM Biosciences
Biotech company based in Shanghai.
Onelife Nutriscience
Onelife Nutriscience is a consumer healthcare brands company.
O2 Spa
O2 Spa a health care company.
Organ Technologies
Organ Technologies is a biotech and healthcare company.
Origo Biopharma
Origo Biopharma is a biotech company.
Xingmu Biotech
Xingmu Biotech is a Healthcare company.
Xgene Pharmaceutical
Xgene Pharmaceutical is a pharmaceutical company.
Xihua Scientific
Xihua Scientific is a Healthcare company.
ZeroBrush
ZeroBrush is a healthcare service company.
Circumvent
Circumvent is a biotech company
Oranger
Oranger is a Healthcare company.
Creative Biosciences
Creative Biosciences is a biomedical technology company.
Concepta PLC
Concepta PLC is a healthcare company.
Causeway Therapeutics
A bio pharmaceutical spin out emerging.
CGeneTech
A Chinese bio-pharmaceutical company.
Better Health Group
Better Health Group is a healthcare company.
Phoebus Medical Technology
Phoebus Medical Technology is a Healthcare company.
Pearl Care
Pearl Care is Healthcare company.
Yiyong Health
Yiyong Health is a Healthcare company.
YS Biopharma
YS Biopharma is a global, fully integrated bio-pharmaceutical company.
Yaeher Health
Yaeher Health is a healthcare company.
Yudao Bio
Yudo Bio is a provider of biopharmaceutical products
Founder
Investors List
Temasek Holdings
Temasek Holdings investment in Series A - Curon Biopharma
6 Dimensions Capital
6 Dimensions Capital investment in Series A - Curon Biopharma
Boyu Capital
Boyu Capital investment in Series A - Curon Biopharma
Official Site Inspections
http://www.curonbiopharma.com
- Host name: 47.90.247.155
- IP address: 47.90.247.155
- Location: San Mateo United States
- Latitude: 37.5517
- Longitude: -122.33
- Metro Code: 807
- Timezone: America/Los_Angeles
- Postal: 94402
More informations about "Curon Biopharma"
Curon BioPharma
Contact Us; Expanded Access ProgramSee details»
Curon Biopharma - Crunchbase Company Profile
Curon Biopharma is a developer of drugs intended designed for immuno-oncology therapies. The company's drugs consist of multiple class-leading …See details»
Curon BioPharma
© Curon Biopharmaceutical Limited . Contact UsSee details»
Curon Biopharmaceutical - PitchBook
Curon Biopharmaceutical General Information Description. Developer of drugs designed for immuno-oncology therapies. The company's drugs consist of multiple class-leading cancer …See details»
Curon Biopharmaceutical - LinkedIn
Curon Biopharmaceutical is a Shanghai-based biopharma company. Curon Biopharma currently holds multiple promising novel cancer immuno-therapeutic agents in its pipeline, and is committed to bring ...See details»
Curon Biopharmaceutical Ltd. - Drug pipelines, Patents ... - Patsnap
Explore Curon Biopharmaceutical Ltd. with its drug pipeline, therapeutic area, technology platform, 8 clinical trials, 10 news, and 1 literature, Disease Domain:Neoplasms, Immune …See details»
Curon Biopharmaceutical Limited | Insights
Aug 9, 2024 Already A Biomedtracker Subscriber? You have access to the full company record through your subscription.See details»
Curon Biopharma - Funding, Financials, Valuation & Investors
How much funding has this organization raised over time? Show . Announced Date . Transaction Name . Number of Investors . Money Raised . Lead Investors . Jul 30, 2018: Series A - Curon …See details»
Curon Biopharmaceutical - Products, Competitors, Financials, …
The company also received the European Commission’s (EC) approval of WINREVAIR, in combination with other pulmonary arterial hypertension (PAH) therapies, for the treatment of …See details»
What can we help you find? - MSD
Aug 9, 2024 CN201 is a next generation CD3xCD19 bispecific antibody that augments and diversifies MSD’s pipeline, with potential applications in B-cell malignancies and autoimmune …See details»
Rhizen Pharmaceuticals S.A. and Curon Biopharmaceutical Limited ...
Oct 12, 2020 La Chaux-de-Fonds, Switzerland and Shanghai, China. October 12, 2020, Oct. 12, 2020 (GLOBE NEWSWIRE) -- Rhizen Pharmaceuticals S. A. (Rhizen), a Switzerland-based …See details»
Curon Biopharma completes $150M financing - BioSpectrum Asia
Curon Biopharma completes $150M financing 01 August 2018 | News It will use the proceeds from the financing to accelerate its pipeline assets into pre-clinical and clinical phases asSee details»
Curon BioPharma
To become an innovative, fully integrated, global biopharmaceutical company. Cure for the Incurable . Hope for the Hopeless. PipelineSee details»
Curon Biopharmaceutical Ltd. (同润生物医药（上海）有限公司)
了解Curon Biopharmaceutical Ltd. (同润生物医药（上海）有限公司)公司的药物管线，治疗领域，技术平台，以及它的8项临床试验, 1篇新闻和1篇文献，疾病领域:肿瘤，免疫系统疾病，血 …See details»
Curon Biopharma of Shanghai Completes $150 Million Initial …
Jul 31, 2018 Curon Biophama, a Shanghai immuno-oncology startup, announced a $150 million Series A financing. 6 Dimensions Capital incubated the company and participated in the …See details»
Curon BioPharma
Web site maintenance!See details»
Rhizen signs oncology drug development deal with Curon
Oct 13, 2020 Rhizen signs oncology drug development deal with Curon. Swiss biopharma company Rhizen Pharmaceuticals has signed an exclusive licensing agreement with Curon …See details»
Temasek backs $150m Series A in Chinese startup Curon Biopharma
Aug 1, 2018 Shanghai-based biopharma firm Curon Biopharmaceutical has announced the completion of its Series A funding round, which raised $150 million from Temasek, 6 …See details»
Wilson Sonsini Advises Curon on $149 Million Deal for China …
On October 12, 2020, Curon Biopharma, a Shanghai-based clinical-stage biopharmaceutical company, acquired exclusive rights to Tenalisib from Rhizen Pharma of Switzerland for …See details»
Week In Review: Curon Bio Acquires Rights To Lymphoma Drug In …
Oct 18, 2020 Deals and Financings. Curon Biopharma, a Shanghai clinical-stage in-licensing company, acquired China rights to Tenalisib, a dual PI3K delta and gamma inhibitor, from …See details»